Citadel Advisors »

Keros Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Keros Therapeutics (KROS) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Keros Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Keros Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Keros Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $42M 722k 58.07
2024-06-30 $19M 414k 45.70
2024-03-31 $31M 468k 66.20
2023-12-31 $30M 764k 39.76
2023-09-30 $13M 406k 31.88
2023-06-30 $13M 329k 40.18
2023-03-31 $16M 373k 42.70
2022-12-31 $20M 424k 48.02
2022-06-30 $10M 372k 27.63
2022-03-31 $16M 287k 54.38
2021-12-31 $18M 303k 58.51
2021-09-30 $11M 274k 39.56
2021-06-30 $5.0M 118k 42.48
2021-03-31 $7.8M 128k 61.04
2020-12-31 $19M 269k 70.54
2020-06-30 $5.9M 157k 37.51